Acute toxicity of two Alzheimer’s disease radiopharmaceuticals: FDDNP and IMPY

References

• Agdeppa, E. D., Kepe. V., Liu, J., Flores-Torres, S., Satyamurthy, N., Petric, A., et al. (2001). Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer’s disease. J Neurosci 21:RC189.
   PubMed Web of Science ®Google Scholar
• Agdeppa, E. D., Kepe, V., Liu, J., Small, G. W., Huang, S. C., Petric, A., et al. (2003b). 2-dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer’s disease. Mol Imaging Biol 5:404–417.
   PubMedGoogle Scholar
• Agdeppa, E. D., Kepe, V., Petri, A., Satyamurthy, N., Liu, J., Huang, S. C., et al. (2003a). In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer’s brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene)malononitrile. Neuroscience 117:723–730.
   PubMed Web of Science ®Google Scholar
• Barrio, J. R. Kepe, V., Satyamurthy, N., Huang, S. C., Small, G. W. (2006). Brain pathology and neuronal losses in the living brain of Alzheimer’s patients. Int Congr Series 1290:150–155.
   Google Scholar
• Brendza, R. P., Bacskai, B. J., Cirrito, J. R., Simmons, K. A., Skoch, J. M., Klunk, W. E., et al. (2005). Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J Clin Invest 15:428–433.
   Google Scholar
• Cleary, J., Hittner, J. M., Semotuk, M., Mantyh, P., O’Hare, E. (1995). Beta-amyloid (1–40) effects on behavior and memory. Brain Res 682(1–2):69–74.
   PubMed Web of Science ®Google Scholar
• Gordon, M. N., King, D. L., Diamond, D. M., Jantzen, P. T., Boyett, K. V., Hope, C. E., et al. (2001). Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiol Aging 22:377–385.
   PubMed Web of Science ®Google Scholar
• Klunk, W. E., Wang, Y., Huang, G. F., Debnath, M. L., Holt, D. P., Mathis, C. A. (2001). Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 69:1471–1484.
   PubMed Web of Science ®Google Scholar
• Kulkarni, P. V., Arora V., Roney, A. V., White, C., III, Bennett, M., Antich, P. P., (2005). Radiolabeled probes for imaging Alzheimer’s plaques. Nucl Instr Meth Phys Res B 241:676–680.
   Web of Science ®Google Scholar
• Kung, M. P., Hou, C., Zhuang, Z. P., Skovronsky, D., Kung. H. F. (2004a). Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer’s disease. Brain Res 1025(1–2):98–105.
   PubMed Web of Science ®Google Scholar
• Kung, M. P., Hou, C., Zhuang, Z. P., Cross, A. J., Maier, D. L., Kung, H. F. (2004b). Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice. Eur J Nucl Med Mol Imaging 31:1136–1145.
   PubMed Web of Science ®Google Scholar
• Kung, M. P., Hou, C., Zhuang, Z. P., Zhang, B., Skovronsky, D., Trojanowski, J. Q., et al. (2002). IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques. Brain Res 956:202–210.
   PubMed Web of Science ®Google Scholar
• Kung, H. F., Kung, M. P., Zhuang, Z. P., Hou, C., Lee, C. W., Plossl, K., et al. (2003). Iodinated tracers for imaging amyloid plaques in the brain. Mol Imaging Biol 5:418–426.
   PubMedGoogle Scholar
• Lee, C. W., Kung, M. P., Hou, C., Kung, H. F. (2003). Dimethylamino-fluorenes: ligands for detecting beta-amyloid plaques in the brain. Nucl Med Biol 30:573–580.
   PubMed Web of Science ®Google Scholar
• Liu, J., Kepe, V., Zabjek, A., Petric, A., Padgett, H. C., Satyamurthy, N., et al. (2007). High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]fluoroethyl) (methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) ready for animal or human administration. Mol Imaging Biol 9:6–16.
   PubMed Web of Science ®Google Scholar
• Nakamura, S., Murayama, N., Noshita, T., Annoura, H., Ohno, T. (2001). Progressive brain dysfunction following intracerebroventricular infusion of beta(1–42)-amyloid peptide. Brain Res 912:128–136.
   PubMed Web of Science ®Google Scholar
• Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., et al. (2003). Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409–421.
   PubMed Web of Science ®Google Scholar
• Reiman, E. M., Uecker, A., Gonzalez-Lima, F., Minear, D., Chen, K., Callaway, N. L., et al. (2000). Tracking Alzheimer’s disease in transgenic mice using fluorodeoxyglucose autoradiography. Neuroreport 11:987–991
   PubMed Web of Science ®Google Scholar
• Selkoe, D. J. (2000). The origins of Alzheimer’s disease: a is for amyloid. JAMA 283:1615–1617.
   PubMed Web of Science ®Google Scholar